Isradipine calcium phase 3 clinical trial: slow PD progression?
An ongoing, NIH sponsored, Phase 3 clinical trial in North America is testing the ability of one member of the dihydropyridine class (isradipine) to slow PD...
An ongoing, NIH sponsored, Phase 3 clinical trial in North America is testing th...